In the News: Rev1 Ventures Profiles Pavaka's Founders and Mission
Updated: 5 days ago
COLUMBUS, Ohio — November 6, 2025 — Rev1 Ventures has published a feature on Pavaka Wound Care co-founders Brent Toto and Frank Fischer and their mission. The profile covers how the company's co-founders met and what drives their work.
Written by Rev1's Alicia Oddi, the article describes how CTO and Co-Founder Frank Fischer, after 35 years at Cook Medical, thought he was done launching new medical devices until a mutual connection introduced him to CEO and Co-Founder Brent Toto. "So many technologies die on the shelf because there's no one to take them forward," Fischer told Rev1.
The profile explains the problem Pavaka is working on. Chronic wounds infected with multidrug-resistant bacteria often form protective biofilms that block healing, with a heavy human toll that includes long hospital stays and amputations. It describes Pavaka's battery-powered electroceutical dressing and the company's focus on making the technology practical for hospital and battlefield care. The dressing generates a low-level electric field at the wound surface.
The founders also shared advice for other entrepreneurs. "You'll never have all the answers," Toto said. "If you wait for that, you'll never start." Fischer added: "Keep learning. Talk to people with different views. Even when you don't like what you hear, it's valuable."
The article notes that Pavaka, with support from Rev1 Ventures and grant funding, is working through clinical, regulatory, reimbursement and manufacturing milestones. The goal is to bring a first product to market, subject to the appropriate U.S. Food and Drug Administration review.
The feature was published as Pavaka neared the end of Rev1's Fall 2025 Customer to Capital accelerator, ahead of the program's Investor Showcase later in November.
Pavaka thanks Rev1 Ventures for telling the company's story and for its continued support of Ohio founders.
The profile also reflects how Pavaka thinks about its platform over the long term. The company and Rev1 both describe potential applications beyond wounds, including other bacterial, fungal and viral conditions, as future directions for research.
"Frank and I came to this from very different paths, but we share the conviction that good science shouldn't die on the shelf. We're grateful to Rev1 for telling that story." — Brent Toto, CEO and Co-Founder
Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.
About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.




Comments